Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Income from Continuing Operations (2016 - 2025)

Jaguar Health (JAGX) has disclosed Income from Continuing Operations for 11 consecutive years, with 7244000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Income from Continuing Operations fell 2.03% to 7244000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was 30857000.0, a 12.85% increase, with the full-year FY2024 number at 39251000.0, up 6.32% from a year prior.
  • Income from Continuing Operations was 7244000.0 for Q3 2025 at Jaguar Health, up from 7992000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 5025000.0 in Q4 2024 to a low of 18164000.0 in Q1 2022.
  • A 5-year average of 10518368.42 and a median of 9628000.0 in 2024 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: tumbled 63.28% in 2021, then skyrocketed 46.02% in 2024.
  • Jaguar Health's Income from Continuing Operations stood at 14318000.0 in 2021, then soared by 42.51% to 8232000.0 in 2022, then fell by 13.08% to 9309000.0 in 2023, then surged by 46.02% to 5025000.0 in 2024, then tumbled by 44.16% to 7244000.0 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Income from Continuing Operations are 7244000.0 (Q3 2025), 7992000.0 (Q2 2025), and 10596000.0 (Q1 2025).